How a mother's immune system accepts pregnancy in the first trimester
Official title: Mechanisms of Maternal Immune Tolerance in Early Pregnancy
Run by University Hospital, Basel, Switzerland · NCT07297394 · Data updated 2026-11-12
We will test how the immune system changes in the first trimester in people undergoing IVF to see which immune patterns support implantation and help prevent early miscarriage.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | March 2, 2026 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT07297394 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 18 or older undergoing IVF/ICSI (including those who become pregnant or experience failed implantation/miscarriage) who can provide written informed consent and attend blood draws at the study site are ideal candidates.
✕Probably not a fit
Individuals with HIV, hepatitis B or C, syphilis, or those taking immunosuppressive medications are excluded and thus will not be eligible, and participants should not expect direct therapeutic benefit from this observational study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, longitudinal study of people undergoing IVF/ICSI that collects blood before embryo transfer, during the first trimester, and after any miscarriage. Samples will be analyzed for immune cell composition, activation states, and cytokine profiles using advanced immunological assays. The design tracks immune changes from pre-implantation through early gestation to identify cellular and molecular signatures linked to successful implantation and tolerance. Results aim to generate markers that could inform future predictive tests or targeted interventions.
Why it matters
Potential benefit: If successful, the study could identify blood-based immune markers that help predict or prevent early pregnancy loss and guide personalized approaches to support implantation.
How similar studies have gone: Previous observational work has linked T cell subsets and cytokine patterns to pregnancy outcomes, but causal mechanisms remain unproven, so this study builds on associative findings rather than testing an established therapy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Blood from patients will be included before and during pregnancies (or failed implantation) conceived through IVF/ICSI (Intracytoplasmic Sperm Injection) treatment and in case of miscarriage. 1. where the patient (pregnant person) was ≥ 18 years of age. 2. where the patient (pregnant person) signed a written informed consent. Exclusion Criteria: 1. Certain maternal infections (HIV, Hepatitis B, Hepatitis C, Syphilis) 2. Patients under immunosuppressive medications (at time of blood sample collection)
Where it's running
-
University Hospital Basel
Basel, Switzerland Recruiting
Study contacts
- Study coordinator: Ursula Gobrecht-Keller, MD
- Email: ursula.gobrecht@usb.ch
- Phone: +41 61 265 93 37
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.